One clinical study has shown that S100A9 represents a reliable biomarker in distinguishing acute progressive ischemic stroke from acute non‐progressive ischemic stroke,50 thus suggesting its potential role in ischemic pathophysiology. The gene discussed is S100A9; the disease is ischemic stroke.